| Editor's Choice: Heart Failure | Bruce Wilkoff, MD, director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, said the new device could be "an important advancement for heart failure patients." Bruce Wilkoff, MD, director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, said the new device could be "an important advancement for heart failure patients." | | |
| The drug, which should be available by the end of June, will be marketed under the name Inpefa. The drug, which should be available by the end of June, will be marketed under the name Inpefa. | | |
| Researchers used multiple AI models to evaluate EHR data from more than 322,000 heart failure patients. By identifying these subtypes, the group thinks clinicians could perform better risk assessments and make more informed treatment decisions. Researchers used multiple AI models to evaluate EHR data from more than 322,000 heart failure patients. By identifying these subtypes, the group thinks clinicians could perform better risk assessments and make more informed treatment decisions. | | |
| The device, described as the "world's smallest heart pump," has received the FDA's breakthrough device designation for two indications. The device, described as the "world's smallest heart pump," has received the FDA's breakthrough device designation for two indications. | | |
| The FDA has previously approved the SGLT2 inhibitor in patients with HFrEF, but not HFmrEF or HFpEF The FDA has previously approved the SGLT2 inhibitor in patients with HFrEF, but not HFmrEF or HFpEF | | |
| | The round was led by two new investors, Novo Holdings and Andera Partners. Several existing investors, including Medtronic, also participated. The round was led by two new investors, Novo Holdings and Andera Partners. Several existing investors, including Medtronic, also participated. | | |
| |
|
| ![]() | |
|
